Planning

Market Engagement - Consultant-led Clinical Review Service for Myalgic Encephalomyelitis and Chronic Fatigue Syndrome (ME/CFS)

  • NHS Shropshire, Telford and Wrekin Integrated Care Board

F01: Prior information notice (prior information only)

Notice identifier: 2026/S 000-009366

Procurement identifier (OCID): ocds-h6vhtk-06152a

Published 3 February 2026, 11:17am



Section one: Contracting authority

one.1) Name and addresses

NHS Shropshire, Telford and Wrekin Integrated Care Board

Wellington Civic Offices, Larkin Way, Tan Bank, Wellington

Telford

TF1 1LX

Contact

Hayley Smith

Email

h.smith27@nhs.net

Country

United Kingdom

Region code

UKG21 - Telford and Wrekin

Justification for not providing organisation identifier

Not on any register

Internet address(es)

Main address

https://www.shropshiretelfordandwrekin.nhs.uk/

Buyer's address

https://www.shropshiretelfordandwrekin.nhs.uk/

one.3) Communication

The procurement documents are available for unrestricted and full direct access, free of charge, at

https://health-family.force.com/s/Welcome

Additional information can be obtained from the above-mentioned address

one.4) Type of the contracting authority

Body governed by public law

one.5) Main activity

Health


Section two: Object

two.1) Scope of the procurement

two.1.1) Title

Market Engagement - Consultant-led Clinical Review Service for Myalgic Encephalomyelitis and Chronic Fatigue Syndrome (ME/CFS)

Reference number

WHISP-364

two.1.2) Main CPV code

  • 85100000 - Health services

two.1.3) Type of contract

Services

two.1.4) Short description

This is an advertisement for market testing only to gauge market interest which will influence future commissioning and procurement direction. This advertisement is issued under the Provider Selection Regime (PSR) of the Healthcare Services Regulations 2023. NHS Shropshire Telford and Wrekin Integrated Care Board ICB (STW ICB) has not decided at this point which PSR process best applies.

NHS Shropshire Telford and Wrekin Integrated Care Board (STW ICB) has a requirement for a Consultant-led Clinical Review Service for existing patients with Myalgic Encephalomyelitis and Chronic Fatigue Syndrome (ME/CFS).

STW ICB are seeking Expressions of Interest (EoIs) from potential providers that are suitably qualified and experienced in delivering ME/CFS Consultant-led Clinical Review Services.

Any Provider wishing to express an interest in delivering the consultant led ME/CFS clinical review service in the Shropshire, Telford and Wrekin (STW) area should register their interest and complete the questionnaire on the Atamis Health Family eCommercial System at https://health-family.force.com/s/Welcome, Atamis reference C415143, no later than 16:00 hours on 23/02/2026.

two.1.5) Estimated total value

Value excluding VAT: £120,000

two.1.6) Information about lots

This contract is divided into lots: No

two.2) Description

two.2.3) Place of performance

NUTS codes
  • UKG21 - Telford and Wrekin
  • UKG22 - Shropshire CC
Main site or place of performance

County of Shropshire - NUTS Codes UKG22 & UKG21

two.2.4) Description of the procurement

Within STW there are currently around 146 patients with Myalgic Encephalomyelitis or Chronic Fatigue Syndrome (ME/CFS) who are overdue their follow up appointment with no consultant-led service in place. These patients have been reviewed by the local Community Trust and have been deemed too complex for the community service at present due to their current management plans.

STW ICB are seeking a provider to deliver a consultant-led clinical review service for existing patients with (ME/CFS). The service is to be provided from a base within STW, to determine their ongoing care requirements in line with one of the following three outcomes:

• Continue active treatment

• Discharge from the service in totality

• Management in community either via local community service or GP

STW ICB are seeking Expressions of Interest (EoIs) from potential providers that are suitably qualified and experienced in delivering an ME/CFS Consultant-led Clinical Review Service.

It is anticipated that any future contract will be for a 3-year period, with an estimated value of £40,000 per annum including VAT (total contract value £120,000). It is intended that this will be issued as a block contract. NHS Standard Contract Terms and Conditions will apply. It is anticipated that the Contract will commence as soon as is practically possible.

This market engagement exercise shall enable STW ICB to help inform the level of interest, capacity and capability of the market for this specialised service, inform the specification and influence future commissioning and procurement direction.

Any Provider wishing to express an interest in delivering this ME/CFS Consultant-led Clinical Review Service in the Shropshire, Telford and Wrekin (STW) area should register their interest and complete the questionnaire on the Atamis Health Family eCommercial System at https://health-family.force.com/s/Welcome, Atamis reference C415143, no later than 16:00 hours on 23/02/2026

STW ICB is only seeking expressions of interest from providers who are attracted to this potential opportunity and capable of providing the service. Please only express an interest if you have the relevant authority to do so on behalf of your organisation.

The ICB reserves the right not only to change/amend it's approach but also reserves the right not to proceed with a procurement, and is not bound to follow through on any EoI received.

Please note those organisations that have expressed an interest will still be required to register separately for any future procurement and should not rely on their response to this EoI. Interested parties will not be prejudiced by any response or failure to respond to this notice. Nor shall a response to this Market Engagement Notice guarantee an invitation to participate in any future procurement process.

two.3) Estimated date of publication of contract notice

1 April 2026


Section four. Procedure

four.1) Description

four.1.8) Information about the Government Procurement Agreement (GPA)

The procurement is covered by the Government Procurement Agreement: No


Section six. Complementary information

six.3) Additional information

It should be noted that this is not a procurement exercise at this stage and participating organisations are responsible for their own costs. All details provided by STW ICB are in draft format, and STW ICB reserves the right to change/amend any aspect of its requirement prior to any potential future procurement exercise.

The ICB reserves the right not only to change/amend it's approach, but also reserves the right not to proceed with a procurement.

The Commissioner reserves the right to contact any provider in reference their response, though the Commissioner is not committed to do so.

To register your Expression of Interest (EOI) please complete the questionnaire on the Atamis Health Family eCommercial System https://health-family.force.com/s/Welcome, reference C415143.

The closing date for EoIs is 16:00 hours on 23/02/2026.

This is a Provider Selection Regime (PSR) market engagement notice. Should STW ICB award any contract subsequent to this request, it will be subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Procurement Act 2023 do not apply to this notice.

STW ICB is not bound to act on any information generated from the questionnaire, and participation does not automatically guarantee any standing with regards to any future PSR process adopted by STW ICB.